LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Integrative Profiling of Amyotrophic Lateral Sclerosis Lymphoblasts Identifies Unique Metabolic and Mitochondrial Disease Fingerprints.

    Cunha-Oliveira, Teresa / Carvalho, Marcelo / Sardão, Vilma / Ferreiro, Elisabete / Mena, Débora / Pereira, Francisco B / Borges, Fernanda / Oliveira, Paulo J / Silva, Filomena S G

    Molecular neurobiology

    2022  Volume 59, Issue 10, Page(s) 6373–6396

    Abstract: Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease with a rapid progression and no effective treatment. Metabolic and mitochondrial alterations in peripheral tissues of ALS patients may present diagnostic and therapeutic ... ...

    Abstract Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease with a rapid progression and no effective treatment. Metabolic and mitochondrial alterations in peripheral tissues of ALS patients may present diagnostic and therapeutic interest. We aimed to identify mitochondrial fingerprints in lymphoblast from ALS patients harboring SOD1 mutations (mutSOD1) or with unidentified mutations (undSOD1), compared with age-/sex-matched controls. Three groups of lymphoblasts, from mutSOD1 or undSOD1 ALS patients and age-/sex-matched controls, were obtained from Coriell Biobank and divided into 3 age-/sex-matched cohorts. Mitochondria-associated metabolic pathways were analyzed using Seahorse MitoStress and ATP Rate assays, complemented with metabolic phenotype microarrays, metabolite levels, gene expression, and protein expression and activity. Pooled (all cohorts) and paired (intra-cohort) analyses were performed by using bioinformatic tools, and the features with higher information gain values were selected and used for principal component analysis and Naïve Bayes classification. Considering the group as a target, the features that contributed to better segregation of control, undSOD1, and mutSOD1 were found to be the protein levels of Tfam and glycolytic ATP production rate. Metabolic phenotypic profiles in lymphoblasts from ALS patients with mutSOD1 and undSOD1 revealed unique age-dependent different substrate oxidation profiles. For most parameters, different patterns of variation in experimental endpoints in lymphoblasts were found between cohorts, which may be due to the age or sex of the donor. In the present work, we investigated several metabolic and mitochondrial hallmarks in lymphoblasts from each donor, and although a high heterogeneity of results was found, we identified specific metabolic and mitochondrial fingerprints, especially protein levels of Tfam and glycolytic ATP production rate, that may have a diagnostic and therapeutic interest.
    MeSH term(s) Adenosine Triphosphate ; Amyotrophic Lateral Sclerosis/genetics ; Amyotrophic Lateral Sclerosis/metabolism ; Bayes Theorem ; Humans ; Mitochondrial Diseases ; Mutation/genetics ; Neurodegenerative Diseases ; Superoxide Dismutase/metabolism ; Superoxide Dismutase-1/genetics
    Chemical Substances Adenosine Triphosphate (8L70Q75FXE) ; Superoxide Dismutase (EC 1.15.1.1) ; Superoxide Dismutase-1 (EC 1.15.1.1)
    Language English
    Publishing date 2022-08-06
    Publishing country United States
    Document type Journal Article
    ZDB-ID 645020-9
    ISSN 1559-1182 ; 0893-7648
    ISSN (online) 1559-1182
    ISSN 0893-7648
    DOI 10.1007/s12035-022-02980-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Liraglutide Protects Against Brain Amyloid-β

    Duarte, Ana I / Candeias, Emanuel / Alves, Inês N / Mena, Débora / Silva, Daniela F / Machado, Nuno J / Campos, Elisa J / Santos, Maria S / Oliveira, Catarina R / Moreira, Paula I

    International journal of molecular sciences

    2020  Volume 21, Issue 5

    Abstract: Alzheimer's disease (AD) is the most common form of dementia worldwide, being characterized by the deposition of senile plaques, neurofibrillary tangles (enriched in the amyloid beta (Aβ) peptide and hyperphosphorylated tau (p-tau), respectively) and ... ...

    Abstract Alzheimer's disease (AD) is the most common form of dementia worldwide, being characterized by the deposition of senile plaques, neurofibrillary tangles (enriched in the amyloid beta (Aβ) peptide and hyperphosphorylated tau (p-tau), respectively) and memory loss. Aging, type 2 diabetes (T2D) and female sex (especially after menopause) are risk factors for AD, but their crosslinking mechanisms remain unclear. Most clinical trials targeting AD neuropathology failed and it remains incurable. However, evidence suggests that effective anti-T2D drugs, such as the GLP-1 mimetic and neuroprotector liraglutide, can be also efficient against AD. Thus, we aimed to study the benefits of a peripheral liraglutide treatment in AD female mice. We used blood and brain cortical lysates from 10-month-old 3xTg-AD female mice, treated for 28 days with liraglutide (0.2 mg/kg, once/day) to evaluate parameters affected in AD (e.g., Aβ and p-tau, motor and cognitive function, glucose metabolism, inflammation and oxidative/nitrosative stress). Despite the limited signs of cognitive changes in mature female mice, liraglutide only reduced their cortical Aβ
    MeSH term(s) Alzheimer Disease/metabolism ; Amyloid beta-Peptides/metabolism ; Animals ; Behavior, Animal ; Brain/metabolism ; Cyclic AMP-Dependent Protein Kinases/metabolism ; Diabetes Mellitus, Type 2/metabolism ; Estradiol/metabolism ; Female ; Glucagon-Like Peptide 1/metabolism ; Glycolysis ; Hypoglycemic Agents/pharmacology ; Inflammation/metabolism ; Liraglutide/pharmacology ; Maze Learning ; Memory Disorders ; Mice ; Neurofibrillary Tangles/metabolism ; Nitrosative Stress ; Oxidative Stress ; Peptide Fragments/metabolism ; Phenotype ; Plaque, Amyloid/metabolism
    Chemical Substances Amyloid beta-Peptides ; Hypoglycemic Agents ; Peptide Fragments ; amyloid beta-protein (1-42) ; Estradiol (4TI98Z838E) ; Liraglutide (839I73S42A) ; Glucagon-Like Peptide 1 (89750-14-1) ; Cyclic AMP-Dependent Protein Kinases (EC 2.7.11.11)
    Language English
    Publishing date 2020-03-04
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms21051746
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Riluzole-Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis.

    Albertini, Claudia / Salerno, Alessandra / Atzeni, Silvia / Uliassi, Elisa / Massenzio, Francesca / Maruca, Annalisa / Rocca, Roberta / Mecava, Marko / Silva, Filomena S G / Mena, Débora / Valente, Pedro / Duarte, Ana I / Chavarria, Daniel / Bissaro, Maicol / Moro, Stefano / Federico, Stephanie / Spalluto, Giampiero / Soukup, Ondřej / Borges, Fernanda /
    Alcaro, Stefano / Monti, Barbara / Oliveira, Paulo J / Menéndez, Josè C / Bolognesi, Maria Laura

    ACS chemical neuroscience

    2022  Volume 13, Issue 15, Page(s) 2252–2260

    Abstract: Polypharmacology is a new trend in amyotrophic lateral sclerosis (ALS) therapy and an effective way of addressing a multifactorial etiology involving excitotoxicity, mitochondrial dysfunction, oxidative stress, and microglial activation. Inspired by a ... ...

    Abstract Polypharmacology is a new trend in amyotrophic lateral sclerosis (ALS) therapy and an effective way of addressing a multifactorial etiology involving excitotoxicity, mitochondrial dysfunction, oxidative stress, and microglial activation. Inspired by a reported clinical trial, we converted a riluzole (
    MeSH term(s) Amyotrophic Lateral Sclerosis/drug therapy ; Humans ; Indans ; Ligands ; Neuroprotective Agents/pharmacology ; Neuroprotective Agents/therapeutic use ; Riluzole/pharmacology ; Riluzole/therapeutic use
    Chemical Substances Indans ; Ligands ; Neuroprotective Agents ; rasagiline (003N66TS6T) ; Riluzole (7LJ087RS6F)
    Language English
    Publishing date 2022-07-22
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1948-7193
    ISSN (online) 1948-7193
    DOI 10.1021/acschemneuro.2c00261
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top